Zobrazeno 1 - 10
of 140
pro vyhledávání: '"A. J. G. Swaak"'
Publikováno v:
International Journal of Rheumatology, Vol 2009 (2009)
Propylthiouracil (PTU) is a frequently prescribed drug in the treatment of hyperthyroidism. The use of PTU is, however, accompanied by numerous potentially serious side effects including vasculitis. PTU-related vasculitides can present as haematuria,
Externí odkaz:
https://doaj.org/article/89cff1d0ba034ca8b4d077a85222353e
Autor:
Alexander M.M. Eggermont, Sandra Collette, Els R. de Groot, Lucien A. Aarden, A. J. G. Swaak, Wim H. J. Kruit, Stefan Suciu, Timo L.M. ten Hagen, Marna G. Bouwhuis
Publikováno v:
Melanoma Research, 21(4), 344-351. Lippincott Williams & Wilkins
Melanoma research, 21(4), 344-351. Lippincott Williams and Wilkins
Melanoma research, 21(4), 344-351. Lippincott Williams and Wilkins
Adjuvant therapy with interferon-alpha (IFN) only benefits a small subgroup of melanoma patients and a predictive marker selecting responders does not exist. IFN induces increased ferritin and decreased C-reactive protein (CRP) levels; however, an as
Publikováno v:
International Journal of Rheumatology
International Journal of Rheumatology, Vol 2009 (2009)
International Journal of Rheumatology, Vol 2009 (2009)
Propylthiouracil (PTU) is a frequently prescribed drug in the treatment of hyperthyroidism. The use of PTU is, however, accompanied by numerous potentially serious side effects including vasculitis. PTU-related vasculitides can present as haematuria,
Publikováno v:
European Journal of Clinical Investigation. 32:79-83
BACKGROUND Adult onset of Still's disease is characterized by very high serum ferritin levels, in disproportion with other acute phase proteins (APPs). Because interferon-alpha (IFN-alpha) was observed to cause hyperferritinaemia in three healthy peo
Publikováno v:
European Journal of Clinical Investigation. 30:336-343
Background Tumour necrosis factor-alpha (TNFa) has been found to be very effective in the isolated limb perfusion setting for advanced extremity tumours. In a phase I study of intrapleural administration of TNFa 5 patients were followed for inflammat
Publikováno v:
Clinical Rheumatology, 19(6), 458-463. Springer London
This cohort study evaluates the postoperative prevalence of antinuclear antibodies (ANA) in relation to symptoms related to the so-called silicone-related symptom complex (SRSC). A total of 63 women who underwent mastectomy followed by immediate brea
Autor:
Z. Domljan, S. Tosi, J. R. Kalden, H. G. Van Den Brink, Marta Mosca, H. Chwalinska-Sadowska, Stefano Bombardieri, R. Fischer, Nada Čikeš, Matthias Schneider, K. Manger, G. Pokorny, Antonio Marchesoni, Attila Kovács, Emese Kiss, H. M. Moutsopoulos, Blaž Rozman, Winfried Graninger, B. Dratwianka, Panayiotis G. Vlachoyiannopoulos, A. Branimir, Josef S. Smolen, Ruud J.T. Smeenk, A. J. G. Swaak, D. Logar, László Kovács
Publikováno v:
Rheumatology. 38:953-958
Objective. Most information available about the disease course of patients with systemic lupus erythematosus (SLE) is restricted to the first 5 yr after disease onset. Data about the disease course 10 yr after disease onset are rare. The aim of this
Autor:
G. Vreugdenhil, H. R. M. Peeters, Ferdinand Breedveld, A. J. G. Swaak, Carla Bakker, Mojca Jongen-Lavrencic
Publikováno v:
Rheumatology International. 18:201-206
Treatment with recombinant human erythropoietin (r-hu-Epo) in patients with rheumatoid arthritis (RA) and anaemia of chronic disease (ACD) resulted in improvement of both anaemia and disease activity. Utilities represent a generic and comprehensive q
Autor:
Bin B. R. Kroon, Omgo E. Nieweg, A. J. G. Swaak, Alexander M.M. Eggermont, Albert N. van Geel, Bart C. Vrouenraets, Aernout C. Ogilvie
Publikováno v:
Annals of Surgical Oncology, 6(4), 405-412. Springer New York
Background: Severe systemic toxicity and hemodynamic changes after isolated limb perfusion (ILP) with tumor necrosis factor-α (TNF-α) and melphalan, with or without interferon-γ, have been reported in several series. We studied whether these side
Autor:
R.A.E.M. Tollenaar, M R de Vries, C. E. Hack, P.J.K. Kuppen, A. M. M. Eggermont, I. H. M. Borel Rinkes, A. J. G. Swaak, T. Wiggers, C.J.H. van de Velde
Publikováno v:
European Journal of Clinical Investigation. 29:553-560
Background In this study, we have evaluated hepatotoxicity, secondary cytokine production and hepatic acute-phase response (APR) in patients who underwent isolated hepatic perfusion (IHP) with tumour necrosis factor (TNF) a and melphalan for irresect